BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22899757)

  • 1. "En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia.
    Sallo FB; Peto T; Egan C; Wolf-Schnurrbusch UE; Clemons TE; Gillies MC; Pauleikhoff D; Rubin GS; Chew EY; Bird AC;
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6145-52. PubMed ID: 22899757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia.
    Sallo FB; Peto T; Egan C; Wolf-Schnurrbusch UE; Clemons TE; Gillies MC; Pauleikhoff D; Rubin GS; Chew EY; Bird AC;
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7889-95. PubMed ID: 23092925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal structural alterations and macular sensitivity in idiopathic macular telangiectasia type 1.
    Takayama K; Ooto S; Tamura H; Yamashiro K; Otani A; Tsujikawa A; Yoshimura N
    Retina; 2012 Oct; 32(9):1973-80. PubMed ID: 22487581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2.
    Mukherjee D; Lad EM; Vann RR; Jaffe SJ; Clemons TE; Friedlander M; Chew EY; Jaffe GJ; Farsiu S;
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO291-BIO299. PubMed ID: 28973315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
    Pauleikhoff D; Gunnemann F; Book M; Rothaus K
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microperimetry Features of Geographic Atrophy Identified With En Face Optical Coherence Tomography.
    Pilotto E; Convento E; Guidolin F; Abalsamo CK; Longhin E; Parrozzani R; Midena E
    JAMA Ophthalmol; 2016 Aug; 134(8):873-9. PubMed ID: 27253760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "En face" optical coherence tomography imaging in type 2 idiopathic macular telangiectasia.
    Wolff B; Basdekidou C; Vasseur V; Sahel JA; Gaudric A; Mauget-Faÿsse M
    Retina; 2014 Oct; 34(10):2072-8. PubMed ID: 25255245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
    Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Relevance of Hyper-Reflectivity in Macular Telangiectasia Type 2.
    Tzaridis S; Friedlander M;
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):6. PubMed ID: 33661283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.
    Runkle AP; Kaiser PK; Srivastava SK; Schachat AP; Reese JL; Ehlers JP
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3683-3689. PubMed ID: 28727884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.
    Pauleikhoff D; Bonelli R; Dubis AM; Gunnemann F; Rothaus K; Charbel Issa P; Heeren TF; Peto T; Clemons TE; Chew EY; Bird AC; Sallo FB;
    Acta Ophthalmol; 2019 Nov; 97(7):e998-e1005. PubMed ID: 30968592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. En face spectral-domain optical coherence tomography outer retinal analysis and relation to visual acuity.
    Kiernan DF; Zelkha R; Hariprasad SM; Lim JI; Blair MP; Mieler WF
    Retina; 2012 Jun; 32(6):1077-86. PubMed ID: 22466459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Retinal Sensitivity Using Optical Coherence Tomography With Deep-Learning Algorithms in Macular Telangiectasia Type 2.
    Kihara Y; Heeren TFC; Lee CS; Wu Y; Xiao S; Tzaridis S; Holz FG; Charbel Issa P; Egan CA; Lee AY
    JAMA Netw Open; 2019 Feb; 2(2):e188029. PubMed ID: 30735236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of a method for en face imaging of photoreceptor cell integrity.
    Wanek J; Zelkha R; Lim JI; Shahidi M
    Am J Ophthalmol; 2011 Nov; 152(5):807-14.e1. PubMed ID: 21764030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral-domain optical coherence tomography measurements of choroidal thickness and outer retinal disruption in macular telangiectasia type 2.
    Nunes RP; Goldhardt R; de Amorim Garcia Filho CA; Thorell MR; Abbey AM; Kuriyan AE; Modi YS; Shah M; Yehoshua Z; Gregori G; Feuer W; Rosenfeld PJ
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):162-70. PubMed ID: 25707040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
    Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
    Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal crystals in type 2 idiopathic macular telangiectasia.
    Sallo FB; Leung I; Chung M; Wolf-Schnurrbusch UE; Dubra A; Williams DR; Clemons T; Pauleikhoff D; Bird AC; Peto T;
    Ophthalmology; 2011 Dec; 118(12):2461-7. PubMed ID: 21839520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of cystoid spaces in type 2 idiopathic macular telangiectasia on spectral domain optical coherence tomography images.
    Oh JH; Oh J; Togloom A; Kim SW; Huh K
    Retina; 2014 Jun; 34(6):1123-31. PubMed ID: 24240556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
    Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.